IB

Inflammatory Bowel Diseases

Inflammatory Bowel Diseases publishes original basic science, translational, and clinical research regarding pathogenesis, epidemiology, evaluation, and treatment of IBD that will lead to advancements in overall clinical care.

Looking to publish in Inflammatory Bowel Diseases? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Gastroenterology & Hepatology
Impact Factor 4.3
Quartile Q1
Open Access Type Hybrid
ISSN 1078-0998
eISSN 1536-4844
Invitation Only No
Cost Range No charge for non-Open Access licenses. An Open Access charge applies for publication under an Open Access license.

Submission Instructions

Inflammatory Bowel Diseases accepts the following article types. Click on an article type to view submission instructions.

Review Articles

Cover Letter AI use to help generate content or images, write code, process data, or provide translation must be disclosed in the cover letter. Cover letter must disclose any AI use to help generate content or images, write code, process data, or provide translation.
Abstract Abstract is required for Review Articles. Abstract must not exceed 250 words. Abstract does not need to be structured.
Manuscript Manuscript body must be 7,000 words, excluding references, figures, and tables. Review Articles must be classified as Basic Science, Translational, or Clinical. Manuscript must include a brief 40-word summary of the article's main point, three to five keywords, Key Messages after the abstract with the bullets 'What is already known?,' 'What is new here?,' and 'How can this study help patient care?,' no more than one sentence per point and no more than 100 words total, and any AI use disclosure in the Methods or Acknowledgements section.
References Review Articles may include no more than 100 references. References must follow American Medical Association Manual of Style, 11th edition. References must be cited in text in order of appearance, and when a reference has more than three authors only the first three should be listed followed by et al.
Figures & Tables Review Articles may include no more than six tables and figures combined. Figures must be submitted as separate files and not embedded within the main text, and tables must not be embedded within the body of the manuscript. Alt text descriptions must be provided for all images, figures, illustrations, and photographs in the main manuscript file directly under the relevant figure legend preceded by 'Alt text:'.
Reformat to Inflammatory Bowel Diseases using Livewrite Premium

Original Articles

Cover Letter A cover letter is required to disclose any use of AI to generate content or images, write code, process data, or provide translation. The cover letter must disclose any use of AI to generate content or images, write code, process data, or provide translation.
Abstract An abstract is required for Original Articles. The abstract must not exceed 250 words. The abstract should be structured. The abstract should be sectioned into Background, Methods, Results, and Conclusions.
Manuscript The manuscript body must not exceed 7,000 words, excluding references, figures, and tables. The manuscript should be organized as Abstract and Key Words, Key Messages, Introduction, Materials and Methods, Results, Discussion, Acknowledgments, Ethical Considerations, References, Tables, and Figure Legends. The manuscript must include a 40-word summary, three to five keywords, Key Messages of no more than 100 words using the bullet points 'What is already known?,' 'What is new here?,' and 'How can this study help patient care?,' and an AI disclosure in the Methods or Acknowledgements section if applicable.
References No more than 40 references may be included. References must follow American Medical Association Manual of Style, 11th edition. References must be cited in text in order of appearance, and for works with more than three authors only the first three authors should be listed followed by et al.
Figures & Tables No more than seven tables and figures combined may be included. Figures and tables must be uploaded separately and not embedded within the manuscript body. Alt text must be provided in the main manuscript file directly under each relevant figure legend and preceded by 'Alt text:'.
Reformat to Inflammatory Bowel Diseases using Livewrite Premium

Brief Reports

Cover Letter Cover letter must disclose any AI use to generate content or images, write code, process data, or provide translation. Cover letter must include disclosure of any AI use to generate content or images, write code, process data, or provide translation.
Abstract Abstract must not be included.
Manuscript Manuscript body must be 1,500 words, excluding references, figures, and tables. Manuscript must include Introduction, Methods, Results, and Discussion. Manuscript must be classified as Basic Science, Translational, or Clinical and must include a 40-word summary of the article’s main point.
References References must not exceed 10. References must follow AMA style, 11th edition. References must be cited in text in order of appearance, and for works with more than three authors only the first three should be listed followed by et al.
Figures & Tables No more than two tables and figures combined may be included. Figures must be submitted as separate files and not embedded within the main text, and tables must not be embedded within the body of the manuscript. Supplemental data, including tables and figures, must not be included.
Reformat to Inflammatory Bowel Diseases using Livewrite Premium

Letters To The Editor

Cover Letter Any use of AI to generate content or images, write code, process data, or provide translation must be disclosed in the cover letter.
Abstract Abstract must not exceed 250 words. Abstract should be structured. Abstract should be sectioned into Background, Methods, Results, and Conclusions.
Manuscript Manuscript body must not exceed 400 words. Letter must begin with the phrase "To the Editors,". A brief 40-word summary, three to five keywords, Key Messages, and AI disclosures in the Methods or Acknowledgements section are required.
References No more than 10 references may be included. References must follow American Medical Association Manual of Style, 11th edition. References must be cited in text in order of appearance, and for works with more than three authors only the first three should be listed followed by et al.
Figures & Tables No more than one table or one figure may be included. Figures must be uploaded as separate files rather than embedded in the main text, and tables must not be embedded within the manuscript body. Alt text must be provided in the main manuscript file directly under each relevant figure legend.
Reformat to Inflammatory Bowel Diseases using Livewrite Premium

Clinical Practice Guidelines

Cover Letter A cover letter is required if AI was used to generate content or images, write code, process data, or provide translation. The cover letter must disclose any AI use to generate content or images, write code, process data, or provide translation.
Abstract An abstract is required. Abstract must not exceed 250 words. Abstract should be structured. Abstract should use the headings Background, Methods, Results, and Conclusions.
Manuscript The manuscript must include a brief 40-word summary of the article's main point, three to five keywords, Key Messages of no more than 100 words after the abstract, and disclosure of any AI use in the Methods or Acknowledgements section.
References References must follow American Medical Association Manual of Style, 11th edition. References must be cited in text in order of appearance, and references with more than three authors should list the first three followed by et al.
Figures & Tables Figures and tables must be uploaded separately and must not be embedded within the main manuscript text. Alt text must be provided in the main manuscript file under each relevant figure legend, and tables must be provided as editable text rather than images.
Reformat to Inflammatory Bowel Diseases using Livewrite Premium

Recent Publications

Transmural healing is significantly associated with prevention of clinical relapse in Crohn’s disease

Aravind G Tamilarasan, Chris Chiu, Dina Bestawros, Stephen Oborn, John Turchini, Jessica Yang, Sudarshan Paramsothy, Rupert Leong

10.1093/ibd/izag041
View Publication

The impact of normalization of histology on disease course in microscopic colitis: a retrospective cohort study

Jennifer Frances Namuli Kizza-Brown, Ashwin N Ananthakrishnan

10.1093/ibd/izag113
View Publication

Distinct predictive factors for acute severe ulcerative colitis in East Asian and Western populations

Eun Soo Kim, Dong Hyun Kim, Seong-Jung Kim, Sang Hyoung Park, Hyun Seok Lee, Sung Kook Kim, Hyun Soo Kim, Jun Lee, Kyeong Ok Kim, Byung Ik Jang, Yoo Jin Lee, Eun Mi Song, Dae Sung Kim, Chun-Chi Lin, Joyce Wing Yan Mak, Jing Liu, Qian Cao, Shu-Chen Wei, Wei-Chen Lin, Wen-Hung Hsu, Shintaro Sagami, Taku Kobayashi, Richard G Fernandes, Robert Gilmore, Yoon-Kyo An, Jakob Begun, Katie Rice, Leonie Ruddick-Collins, Abhinav Vasudevan, Jennifer Zhang, Anthony Brownson, Benjamin Ngoi, Kate Lynch, Craig Haifer, Lucy Mary Lilian Bracken, Ei Swe, Emily Wright, Nicholas Clark, Tamar Schildkraut, Gillian Mahy, Gregory Moore, Kathryn Gazelakis, Mayur Garg, Michael Schultz

10.1093/ibd/izag098
View Publication

Clinical and radiological outcomes of ustekinumab in pediatric perianal Crohn’s disease: a multicenter retrospective study from the Pediatric IBD Porto Group of ESPGHAN

Ido Orlin, Balsam Younis, Marco Gasparetto, Anat Yerushalmy-Feler, Lorenzo Norsa, Christiane Sokollik, Pejman Rohani, Kristýna Zárubová, Giulia D’Arcangelo, Saverio Pochesci, Ana Lozano-Ruf, Kaija-Leena Kolho, Anne Griffiths, Firas Rinawi

10.1093/ibd/izag091
View Publication

Biologics and small molecules for perianal Crohn’s disease: a systematic review and meta-analyses of randomized placebo-controlled trials

Yuhong Yuan, Vipul Jairath, Jurij Hanzel, Marianne Hupe, Rocio Sedano, Mohammad Shehab, Olga Maria Nardone, Fernando Magro, Ailsa Hart, Sudheer Kumar Vuyyuru

10.1093/ibd/izag099
View Publication

Frequently asked questions

How long does it take to publish?

Appeals may take a minimum of 3 to 6 weeks to receive a response from the Editors. Proof corrections must be returned within 48 hours of receipt.

Reformat to Inflammatory Bowel Diseases using Livewrite Premium

Is a cover letter required?

Cover letters are mentioned for disclosure when sharing prior IBD reviews with another journal. Manuscripts posted to a preprint server must be disclosed during submission. AI use should be disclosed in cover letters to editors and in the Methods or Acknowledgements section.

Reformat to Inflammatory Bowel Diseases using Livewrite Premium

What are the publication costs?

Subscription journal with open access publishing options available.

Reformat to Inflammatory Bowel Diseases using Livewrite Premium

Research Topics

Inflammatory Bowel Disease Microscopic Colitis Eosinophilic Esophagitis Helicobacter pylori-related gastroenterology studies Autoimmune and Inflammatory Disorders Immunodeficiency and Autoimmune Disorders Gut microbiota and health Diverticular Disease and Complications Adolescent and Pediatric Healthcare Pregnancy and Medication Impact Gastrointestinal motility and disorders Liver Diseases and Immunity IL-33, ST2, and ILC Pathways Celiac Disease Research and Management Clostridium difficile and Clostridium perfringens research Immune Cell Function and Interaction Mycobacterium research and diagnosis Colorectal Cancer Screening and Detection Autoimmune and Inflammatory Disorders Research Gastrointestinal disorders and treatments Immune Response and Inflammation Diagnosis and treatment of tuberculosis Digestive system and related health Systemic Lupus Erythematosus Research Health Systems, Economic Evaluations, Quality of Life

Related Journals

CA
Clinical and Molecular Hepatology Korean Association for the Study of the Liver
ER
Epidemiologic Reviews Oxford University Press
JR
JAC-Antimicrobial Resistance Oxford University Press
Es
Esophagus Springer Science+Business Media
TA
Therapeutic Advances in Gastroenterology SAGE Publishing
JO
Journal of Public Health Oxford University Press